Australia's Cann Group (ASX:CAN) has entered into an agreement aiming to accelerate registration of a Schedule 3, over-the-counter cannabidiol (CBD) medicine in Australia.While it...

Following the Australian Federal Government's announcement it would permit medicinal cannabis cultivation, New South Wales' state government says it has commenced searching for suitable...

There's a push to commence legal industrial hemp cultivation and production in Hawai'i after the closure of a major sugar cane operation was announced.Last...

Jazz Pharmaceuticals subsidiary GW Pharmaceuticals has announced it has received approval in the UK for the use of Epidyolex to manage seizures associated with...